[Targetability of cell-specific liposomes coated with polysaccharide-cholesterol derivatives].
Sato
T
T
D000818:Animals; D000911:Antibodies, Monoclonal / Q000008:administration & dosage; D002784:Cholesterol; D004317:Doxorubicin / Q000008:administration & dosage; D004337:Drug Carriers; D004355:Drug Stability; D006801:Humans; D000922:Immunotoxins / Q000008:administration & dosage; D008081:Liposomes; D008262:Macrophage Activation; D009369:Neoplasms / Q000188:drug therapy; D011134:Polysaccharides; D014407:Tumor Cells, Cultured
D000911:Antibodies, Monoclonal; D004337:Drug Carriers; D000922:Immunotoxins; D008081:Liposomes; D011134:Polysaccharides; D004317:Doxorubicin; D002784:Cholesterol